New Insights on Concussion Recovery and Glucosamine's Link to Dementia

Recent studies reveal that glucosamine, commonly used for joint pain, may increase the risk of dementia and mortality in patients with existing cognitive impairment. Additionally, moderate screen time could aid concussion recovery in children, challenging previous recommendations to avoid screens entirely post-concussion.

Recent research indicates that glucosamine, a widely-used supplement for joint pain, may pose risks to cognitive health. A study published in Nature Metabolism reveals that regular glucosamine use correlates with a 25% higher likelihood of mild cognitive impairment progressing to dementia. It also associates glucosamine with increased mortality in dementia patients.

The analysis spanning from 2012 to 2024 involved nearly 60,000 patients. Notably, glucosamine's impact was absent in cases of mild cognitive impairment alone. Researchers attribute the findings to a process called hyperglycosylation, where glucosamine prompted abnormal sugar molecule attachments, disrupting key neurological functions.

In a separate study, published in the British Journal of Sports Medicine, experts discovered that moderate screen time could facilitate concussion recovery in children. This contrasts earlier guidance advocating for complete screen abstinence post-concussion. Future clinical trials aim to explore these potential advancements in concussion treatment.